COVID-19 Vaccine Does Not Increase the Risk of Disease Flare-Ups among Patients with Autoimmune and Immune-Mediated Diseases
出版年份 2021 全文链接
标题
COVID-19 Vaccine Does Not Increase the Risk of Disease Flare-Ups among Patients with Autoimmune and Immune-Mediated Diseases
作者
关键词
-
出版物
Journal of Personalized Medicine
Volume 11, Issue 12, Pages 1283
出版商
MDPI AG
发表日期
2021-12-03
DOI
10.3390/jpm11121283
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort
- (2021) Ulf M Geisen et al. ANNALS OF THE RHEUMATIC DISEASES
- Immune-Mediated Disease Flares or New-Onset Disease in 27 Subjects Following mRNA/DNA SARS-CoV-2 Vaccination
- (2021) Abdulla Watad et al. Vaccines
- LB0002 COVID-19 VACCINE SAFETY IN PATIENTS WITH RHEUMATIC AND MUSCULOSKELETAL DISEASE
- (2021) P. M. Machado et al. ANNALS OF THE RHEUMATIC DISEASES
- Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study
- (2021) Victoria Furer et al. ANNALS OF THE RHEUMATIC DISEASES
- Systemic rheumatic disease flares after SARS-CoV-2 vaccination among rheumatology outpatients in New York City
- (2021) Medha Barbhaiya et al. ANNALS OF THE RHEUMATIC DISEASES
- Arthritis of the left elbow joint after vaccination against SARS‐CoV‐2 infection
- (2021) Chokan Baimukhamedov International Journal of Rheumatic Diseases
- mRNA COVID-19 vaccines do not increase the short-term risk of clinical relapses in multiple sclerosis
- (2021) Massimiliano Di Filippo et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Safety of the ChAdOx1 nCoV-19 and the BBV152 vaccines in 724 patients with rheumatic diseases: a post-vaccination cross-sectional survey
- (2021) Somy Cherian et al. RHEUMATOLOGY INTERNATIONAL
- Two-dose COVID-19 vaccination and possible arthritis flare among patients with rheumatoid arthritis in Hong Kong
- (2021) Xue Li et al. ANNALS OF THE RHEUMATIC DISEASES
- Autoimmune phenomena following SARS-CoV-2 vaccination
- (2021) Yuval Ishay et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Administration of COVID-19 vaccines in immunocompromised patients
- (2021) Manica Negahdaripour et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- The state of vaccine safety science: systematic reviews of the evidence
- (2020) Matthew Z Dudley et al. LANCET INFECTIOUS DISEASES
- Measures of Adult Systemic Lupus Erythematosus: Disease Activity and Damage
- (2020) Shilpa Arora et al. ARTHRITIS CARE & RESEARCH
- 2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases
- (2019) Victoria Furer et al. ANNALS OF THE RHEUMATIC DISEASES
- Disease activity in psoriatic arthritis (PsA): defining remission and treatment success using the DAPSA score
- (2015) Monika M Schoels et al. ANNALS OF THE RHEUMATIC DISEASES
- The safety of human papilloma virus-blockers and the risk of triggering autoimmune diseases
- (2015) Britain Baker et al. Expert Opinion On Drug Safety
- EULAR Sjogren's Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjogren's syndrome
- (2011) R. Seror et al. ANNALS OF THE RHEUMATIC DISEASES
- The MG Composite: A valid and reliable outcome measure for myasthenia gravis
- (2010) T. M. Burns et al. NEUROLOGY
- Validation of the 28-joint Disease Activity Score (DAS28) and European League Against Rheumatism response criteria based on C-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on erythrocyte sedimentation rate
- (2008) G Wells et al. ANNALS OF THE RHEUMATIC DISEASES
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started